Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Aptamer Investors - APTA

Share Name	Share Symbol	Market	Stock Type
Aptamer Group Plc	APTA	London	Ordinary Share

	Price Change	Price Change %	Share Price	Last Trade
	0.00	0.00%	0.85	08:00:00

Open Price	Low Price	High Price	Close Price	Previous Close
0.85	0.85	0.85		0.85

more quote information »

Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Top Investor Posts

Top Posts
Posted at 24/4/2024 08:12 by multibagger Good morning No1larafan and all :) Very pleased for you and more strength to you ! Follow the money as they say...you are in good company with the likes of Nic Slater increasing his stake in APTA and has a reputation as a canny investor. TR1s often herald a change in company fortunes and recent developments appear very interesting..... Good luck all ! Read Full Thread Reply
Posted at 21/3/2024 23:26 by icac the board will keep banging drums to their own beats . unfortunately this stock will lose investors all their money. like I said from day one, if aftamer tech was a game changer , all pharmas from big to small would be all signing contracts.. DYOR Read Full Thread Reply
Posted at 20/3/2024 17:06 by icac they need to start bring cash in otherwise needing investors to bail out again.. from over £1 a share down to this current share price Shocking reward for investors. Read Full Thread Reply
Posted at 20/3/2024 11:45 by icac COULD = when ? = 2025 ? 26? 27? we as investors need answers?? but unfortuneatly those answers is not withing Aptamer hands. we can only speculate operating cost getting lower and lower day by day.. so what's next?? 0.40 , or 0.35?? it's obvious discount raise is happening. sorry, had my moan Read Full Thread Reply
Posted at 28/2/2024 17:20 by npk2 He's not the largest investor, Letsbuy1 is. Oops, they're the same person.What happened to.2p next week5p by Xmas Multiple contracts signed( that was back in December)3% RNS for your holdings.Your that far underwater you'll say anything to get gullible investors in here so you can exit breakeven. Read Full Thread Reply
Posted at 28/2/2024 16:28 by icac Amaretto is our largest private investor . I wish you good luck.. we are all in here too, but each investor can have their own views? correct?? no need to be aggressive ok 👌 Read Full Thread Reply
Posted at 22/2/2024 09:37 by wrecktangle Investors finally clocking onto the market cap and the weight of the RNS today? Tick tock. Volume crossed and going strong. Once 1p goes, I reckon every man and his dog will finally see the RNS and how significant it is. Read Full Thread Reply
Posted at 08/2/2024 17:34 by icac most Aim companies always over promise, that's the only way they can suck in investors to invest.. annual profit and loss account do not lie, that's when investors can see the true colour of a company. Read Full Thread Reply
Posted at 31/10/2023 10:54 by stevebrrr 9 Oct 2023 09:40RNS Number : 4126PAptamer Group PLC09 October 20239 October 2023Aptamer Group plc("Aptamer", the "Company" or the "Group")Grant of Options and Related Party TransactionAptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces that it has granted options to subscribe for up to 116,835,918 new ordinary shares to Directors and staff. These awards were set out in the circular and notice of general meeting sent to shareholders on 31 July 2023.Background to the awardsIn August 2023, the Company successfully completed a fundraising without which the Company would in all likelihood have entered an insolvency process. In connection with the fundraising, the Company was changed extensively with the return of Stephen Hull as Executive Chairman (Steve had been chairman prior to the IPO in 2021) and Dr Arron Tolley as Chief Technical Officer (Arron was a founder and had been CEO until April 2023), and the appointment of Dr Adam Hargreaves and Dean Fielding as independent non-executive directors.The proposed options are designed to provide a material incentive to the Directors and other staff, but on stretching revenue and share price performance criteria as set out below, which include achieving returns of at least 4-times and up to 50-times the 1p option exercise price. 60% of the options only vest if the prevailing share price reaches 10-times the option exercise price.Therefore, although the total potential dilution is unusually high at 25%, the structure is such that the Company must deliver exceptional gains to shareholders before the options vest. As part of the recent fundraising, the structure described above and further below was put to investors. In addition, a specific resolution to create the authority to issue shares in connection with the share options was included along with the resolutions giving effect to the July/August 2023 placing and was approved by investors.The Non-executive Directors and Executive Chairman are also receiving awards. Against a very challenging background for the Company, being able to provide equity participation was the most appropriate way to bring a suitable team onto the board to support and challenge the executive. Ordinary cash compensation would not have been sufficient to persuade any of the individuals appointed to join the Company.Details of the awards and termsThe following awards have been made:NamePositionNumber of shares subject to awardsSteve HullExecutive Chairman5,100,000Dr Arron TolleyChief Technical Officer35,837,305Dr David BunkaChief Scientific Officer28,422,450Dean FieldingIndependent Non-Executive Director3,725,000Dr Adam HargreavesIndependent Non-Executive Director3,725,000Andrew RapsonChief Financial Officer - PDMR12,750,000Alastair FlemingChief Operating Officer - PDMR12,750,000Other staff14,526,163 Read Full Thread Reply
Posted at 22/10/2023 20:40 by secretsqu I feel sorry for the silent investors in this Company that don't feel the need to ramp this to the stars. Those that have done their research and invested accordingly.Why?Well if I was looking to invest in this space, I'd do lots of research. That in itself would throw up numerous red flags that would deem it high risk.Then if I was unfortunate enough to come across the Chuckle Brothers whose only offer of analysis is "Whoosh" "30p" "Get in while you can", I'd run a mile.Not one post is backed up by how and why it's going to get to 2p next week, let alone 30p.The red flags I've seen are in the RNSs. It gets worse when you read their nonsense.These 2 beaut's are probably scaring away, way more investors than they could ever attract.But good luck to the other investors here. Read Full Thread Reply

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions